Provided by Tiger Trade Technology Pte. Ltd.

Immunovant, Inc.

41.20
-2.6200-5.98%
Post-market: 40.58-0.6200-1.50%19:30 EDT
Volume:1.08M
Turnover:44.89M
Market Cap:8.50B
PE:-14.62
High:43.38
Open:43.27
Low:41.09
Close:43.82
52wk High:45.42
52wk Low:14.47
Shares:206.40M
Float Shares:89.57M
Volume Ratio:1.06
T/O Rate:1.21%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.8178
EPS(LYR):-2.7716
ROE:-80.10%
ROA:-46.73%
PB:11.56
PE(LYR):-14.86

Loading ...

Immunovant (IMVT) Receives a Rating Update from a Top Analyst

TIPRANKS
·
May 21

Assessing Immunovant (IMVT) Valuation After Strong IMVT-1402 Data And Refocused Pipeline Strategy

Simply Wall St.
·
May 21

Immunovant Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
May 21

Immunovant, Inc. : H.c. Wainwright Raises Target Price to $40 From $35

THOMSON REUTERS
·
May 21

Wells Fargo Sticks to Its Buy Rating for Immunovant (IMVT)

TIPRANKS
·
May 21

U.S. RESEARCH ROUNDUP-Analog Devices, Intuit, Nvidia

Reuters
·
May 21

Immunovant director Atul Pande disposes 6,000 shares for $192,000

Reuters
·
May 21

Top Midday Gainers

MT Newswires Live
·
May 21

Immunovant Stock Surges Despite Disappointing Earnings Miss

Benzinga Earnings
·
May 21

These Stocks Are Today's Movers: Nvidia, Micron, Intel, United, Hasbro, Toll, Immunovant, Analog Devices, and More -- Barrons.com

Dow Jones
·
May 21

This Is Why Immunovant Stock (IMVT) Is Up Today

TIPRANKS
·
May 20

2 Biotech Stocks Are Surging Today Thanks to This Arthritis Drug -- Barrons.com

Dow Jones
·
May 20

Roivant Shares Rise as Focus Intensifies on Key Asset IMVT-1402's Mid-to-Late-Stage Data

Deep News
·
May 20

Stock Track | Immunovant Soars 31.76% Intraday on Promising Rheumatoid Arthritis Drug Trial Data

Stock Track
·
May 20

Immunovant rises 25.9%

TIPRANKS
·
May 20

Immunovant Up Over 25%, on Pace for Largest Percent Increase Since September 2023 -- Data Talk

Dow Jones
·
May 20

Immunovant Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 20

Immunovant Stock Surges 22% on Trial Data. Earnings Are an Afterthought. -- Barrons.com

Dow Jones
·
May 20

Immunovant Shares Surge on Positive Rheumatoid Arthritis Treatment Data

Dow Jones
·
May 20

S&P 500 Futures Rise In Premarket Trading; Immunovant, ImmunityBio Lead

Dow Jones
·
May 20